Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical a

Details Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical a Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical a

1997-03-12

1998-09-22

Lambkin, Deborah C.

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

560 64, 546290, 544162, 549 49, 549 74, 549467, 548182, 514653, 514533, 514345, 5142378, 514443, 514438, 514469, 514369, C07C21500, C07C 6976, A61K 31135, A61K 31235

Patent

active

058115820

ABSTRACT:
Dimethyl-(3-aryl-but-3-enyl)-amine compounds, a method of preparing them, and the use of the compounds as pharmaceutical active ingredients are described.

REFERENCES:
patent: 3956348 (1976-05-01), Hilscher
patent: 3978129 (1976-08-01), Welstead, Jr.
patent: 4173649 (1979-11-01), Sundeen et al.
patent: 4354154 (1982-10-01), Schiemann
patent: 4755599 (1988-07-01), Barriere et al.
patent: 5527821 (1996-06-01), Willman et al.
patent: 5539120 (1996-07-01), Griffith et al.
Dittert et al., "Acetaminophen Prodrugs I: Synthesis, Physicochemical Properties, and Analgesic Activity", Journal of Pharmaceutical Sciences, vol. 57, No. 5, May 1968, pp. 774-780.
Bundgaard et al., "A Novel Solution-Stable, Water-Soluble Prodrug Type for Drugs Containing a Hydroxyl or an NH-Acidc Group", Journal of Medicinal Chemistry, vol. 32, No. 12, Dec. 1989, pp. 2503-2507.
Welch, "Reduction of Aryl Diethyl Phosphates with Titanium Metal: A Method for Deoxygenation of Phenols", J. Org. Chem., vol. 43, No. 25, 1978, pp. 4797-4799.
Olofsson et al., Tetrahedron Letterss, No. 18, pp. 1571-1574, 1977.
Raffa et al., "Opioid and Nonopioid Components Independently Contribute to the Mechanism of Tramadol, an `Atypical` Opioid Analgesic", The Journal of Pharmacology and Experimental Therapeutics, vol. 260, No. 1, pp. 275-285, 1992.
Bundgaard, "Novel Chemical Approaches in Prodrug Design", Drugs of the Future, 1991, 16(5):443-458.
Thorberg et al., J. Med. Chem., vol. 30, No. 11, 1989, pp. 2008-2012.
Jaffe et al., "Chapter 21: Opioid Analgesics and Antagonists" and Jaffe, Chapter 22: Drug Addiction and Drug Abuse, Goodman and Gilman's: The Pharmacological Basis of Therapeutics, Eighth Edition, Pergamon Press, pp. 485-573, 1990.
Winterfeldt, "Applications of Diisobutylaluminum Hydride (DIBAH) and Triisobutylaluminium (TIBA) as Reducing Agents in Organic Synthesis", Synthesis, Oct. 1975, pp. 617-630.
Hilscher, "Splitting of Steroid Ethers", Chemical Abstracts, vol. 84, 1976, Abstract No 84: 59862v, p. 567.
Raffa et al., "Complementary and Synergistic Antinociceptive Interaction between the Enantiomers of Tramadol", Journal of Pharmacology and Experimental Therapeutics, vol. 267, No. 1, pp. 331-340, 1993.
Nazarov et al., Chemical Abstracts, vol. 54, No. 20, Oct. 20, 1960, Abstract No. 20963c.
Hendershot et al., "Antagonism of the Frequency of Phenylquinone-induced Writhing in the Mouse by Weak Analgesics and Nonanalgesics", The Biochemical Research Laboratory, The Dow Chemical Company, Midland, Michigan, Sep. 1958.
Flick et al., Arzneim. -Forsch./Drug Research, 28(1) 1978, pp. 107-113.
Maurer et al., Fresenius Z. Anal. Chem., (1984) 317:42-52.
Kato et al., Chem. Pharm. Bull.,32(6), pp. 2279-2289 (1984).

Affiliated with

Also associated with

Rating

Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1622975